News

Private Management Group, Inc. filed a Schedule 13G Amendment No. 2 with the SEC on November 9, 2026, disclosing a beneficial ownership position in Orion Properties Inc. common stock as of September 30, 2026.

Private Management Group, Inc. filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 1,626,461 shares of Greenlight Capital Re, Ltd. common stock, representing 5.0% of the class, as of September 30, 2026.

Private Management Group, Inc. filed Amendment No. 2 to its Schedule 13G with the SEC on November 9, 2026, disclosing a 9.9% beneficial ownership stake in Cable One, Inc. common stock as of September 30, 2026.

Takeover Time 2026 LLC filed definitive additional soliciting materials with the SEC on November 9, 2026, pressing Cheetah Net Supply Chain Service Inc. stockholders to use a green consent card to replace the company's incumbent board of directors.

Morgan Stanley Finance LLC filed a free writing prospectus on November 9, 2026, disclosing terms for Contingent Income Auto-Callable Securities linked to Novo Nordisk A/S American depositary shares, with a maturity date of December 29, 2027.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed Amendment No. 2 to a Schedule 13G with the SEC on November 9, 2026, disclosing their beneficial ownership of Class A Common Stock in Definitive Healthcare Corp as of September 30, 2026.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed Amendment No. 2 to a Schedule 13G with the SEC, disclosing beneficial ownership of common stock in Karyopharm Therapeutics Inc. as of September 30, 2026.